Researchers were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine. Image: Doherty Institute
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) – a joint venture between the University of Melbourne and the Royal Melbourne hospital – were able to test blood samples at four different time points in an otherwise healthy woman in her 40s, who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.
Published today in Nature Medicine is a detailed report of how the patient’s immune system responded to the virus. One of the authors on the paper, research fellow Dr Oanh Nguyen said this was the first time that broad immune responses to COVID-19 have been reported.
“We looked at the whole breadth of the immune response in this patient using the knowledge we have built over many years of looking at immune responses in patients hospitalised with influenza,” Dr Nguyen said.
“Three days after the patient was admitted, we saw large populations of several immune cells, which are often a tell-tale sign of recovery during seasonal influenza infection, so we predicted that the patient would recover in three days, which is what happened.”
The research team was able to do this research so rapidly thanks to SETREP-ID (Sentinel Travellers and Research Preparedness for Emerging Infectious Disease), led by Royal Melbourne Hospital Infectious Diseases Physician Dr Irani Thevarajan at the Doherty Institute.
SETREP-ID is a platform that enables a broad range of biological sampling to take place in returned travellers in the event of a new and unexpected infectious disease outbreak, which is exactly how COVID-19 started in Australia.
“When COVID-19 emerged, we already had ethics and protocols in place so we could rapidly start looking at the virus and immune system in great detail,” Dr Thevarajan said.
“Already established at a number of Melbourne hospitals, we now plan to roll out SETREP-ID as a national study.”
Working together with University of Melbourne Professor Katherine Kedzierska, a laboratory head at the Doherty Institute and a world-leading influenza immunology researcher, the team were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine.
“We showed that even though COVID-19 is caused by a new virus, in an otherwise healthy person, a robust immune response across different cell types was associated with clinical recovery, similar to what we see in influenza,” Professor Kedzierska said.
“This is an incredible step forward in understanding what drives recovery of COVID-19. People can use our methods to understand the immune responses in larger COVID-19 cohorts, and also understand what’s lacking in those who have fatal outcomes.”
Dr Thevarajan said that current estimates show more than 80 per cent of COVID-19 cases are mild-to-moderate, and understanding the immune response in these mild cases is very important research.
“We hope to now expand our work nationally and internationally to understand why some people die from COVID-19, and build further knowledge to assist in the rapid response of COVID-19 and future emerging viruses,” she said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- US deaths account for 20% of world's total of 2.4M; Johnson & Johnson plans 20M vaccine doses by end of March. Latest COVID-19 updateson February 23, 2021 at 1:01 am
The White House said this weekend that despite the drop in cases this month, life won't return to normal for quite some time. Latest virus updates.
- 'We've done worse than most any other country,' Fauci says as US marks grim Covid-19 death tollon February 23, 2021 at 12:30 am
The US has now surpassed the devastating milestone of half a million Covid-19 deaths. It's a staggering figure that experts say did not have to be this high.
- A Biden edge in COVID-19 bill: Dems reluctant to wound himon February 23, 2021 at 12:28 am
Democrats have a potent dynamic on their side as Congress preps for its first votes on the party’s $1.9 trillion COVID-19 relief bill ...
- A look at northern Italy one year after country’s first COVID-19 caseon February 22, 2021 at 11:42 pm
Italy recorded its first cases of coronavirus and soon became the epicenter for COVID-19 deaths across Europe. Italy was the first country to implement the kind of nationwide lockdowns that the rest ...
- Wealthy LA residents gain access to COVID-19 vaccination codes meant for Black and Latino communitieson February 22, 2021 at 11:09 pm
One source told the LA Times that several of his friends who were "in a bracket where they're very protected," got vaccinated using a code.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Covid-19 immune system response
- COVID-19 Disease Severity May Be Driven by Antibody Responseson February 22, 2021 at 3:59 am
Levels of specific antibodies developed during COVID-19 may influence disease outcomes in both children and adults.
- New way to detect immune overreaction in cancer treatment and COVID–19on February 22, 2021 at 3:13 am
In a new study, researchers developed an “immuno-storm chip” that could diagnose cancer and COVID-19 patients at risk of a potentially lethal reaction. The chip is designed to determine which patients ...
- VACCINE TEAM Q&A: Pain relievers, antibody tests & the immune systemon February 21, 2021 at 7:01 pm
The NBC15 Vaccine Team spoke with Public Health Madison Dane County’s Director Janel Heinrich to get your vaccine questions answered.
- Antibody response may drive COVID-19 outcomeson February 19, 2021 at 7:18 am
Researchers show that levels of specific antibodies developed in the immune response may influence COVID-19 outcomes in both children and adults.
- Modeling New Drug Options, Better Look At Immune Response, Impact of Chromosome 12: COVID-19 Updateson February 18, 2021 at 10:02 pm
Specialized cells in a child’s immune system rapidly target SARS-CoV-2, nasal antiviral blocks transmission in ferrets, machine learning used for drug repurposing, insight into how the virus attacks ...